Significantly increased levels of membrane antigens were found in the severe COVID-19 patients’ EVs that originated from monocyte or macrophages cells (CD14-expressing EVs, p = 0.012) compared to the EVs of the mild COVID-19 patients (p = 0.0186) (Figure 6h). The gene discussed is CD14; the disease is COVID-19.